TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34247394

Group type: EXPERIMENTAL
Intervention: Sit-to-stand training plus routine physiotherapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Routine physiotherapy only
Number of subjects: 38
Study: 32812316

Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone group
Number of subjects: 0
Study: 35716457

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) added to ibuprofen + paracetamol + pregabalin
Number of subjects: 58

Group type: COMPARATOR
Intervention: No Pentoxifylline (Control) with ibuprofen + paracetamol + pregabalin
Number of subjects: 58
Study: 32638858

Group type: COMPARATOR
Intervention: Positive control diet - without phytase or xylanase
Number of subjects: 250

Group type: COMPARATOR
Intervention: Negative control diet - with an energy reduction of 100 kcal/kg, without phytase or xylanase
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Diets containing xylanase and phytase with energy reductions of 50, 100, and 150 Kcal/kg
Number of subjects: 250
Study: 34013489

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Relapse Prevention (MBRP) program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Weekly phone monitoring only (Control Group)
Number of subjects: 70
Study: 33988155

Group type: EXPERIMENTAL
Intervention: Pethidine 50 mg intramuscular injection
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 194
Study: 34435269

Group type: EXPERIMENTAL
Intervention: Interactive, online educational video
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard verbal and written instructions
Number of subjects: 0
Study: 34022364

Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP and RC cerclage
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP, RC cerclage, and 2 anterior 3.5-mm cortical screws
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP, RC cerclage, and additional anterior one-third tubular plate (AAP)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 4-part PHF with LLP and RC cerclage as standard of care
Number of subjects: 27
Study: 34181300

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) over the primary motor cortex (M1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study: 32156788

Group type: EXPERIMENTAL
Intervention: NAVA low (5 cm H2O)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: NAVA high (15 cm H2O)
Number of subjects: 8

Group type: COMPARATOR
Intervention: PSV low (5 cm H2O)
Number of subjects: 8

Group type: COMPARATOR
Intervention: PSV high (15 cm H2O)
Number of subjects: 8
Study: 34251533

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) treatment (660 nm, 100mW, 177 J/cm2, 5 s, 0.5 J) twice a week for 30 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% (corticosteroid)
Number of subjects: 0
Study: 33592310

Group type: EXPERIMENTAL
Intervention: ICUconnect intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 32241164

Group type: EXPERIMENTAL
Intervention: Tooth brushing
Number of subjects: 2435

Group type: COMPARATOR
Intervention: No tooth brushing
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Severe gingivitis
Number of subjects: 2435

Group type: COMPARATOR
Intervention: Healthy periodontium
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Gender (female)
Number of subjects: 2435

Group type: COMPARATOR
Intervention: Gender (male)
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Moderate gingivitis
Number of subjects: 2435

Group type: EXPERIMENTAL
Intervention: Slight gingivitis
Number of subjects: 2435
Study: 34919073

Group type: EXPERIMENTAL
Intervention: VK2+VD3 group (received vitamin K2, vitamin D3, and calcium treatment)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (received only calcium and vitamin D3)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: VK2+VD3 group
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 33406130

Group type: EXPERIMENTAL
Intervention: Health Scouts intervention (community health worker-delivered, theory-based counseling strategy)
Number of subjects: 2148

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2148
Study: 36069950

Group type: EXPERIMENTAL
Intervention: add-on alpha lipoic acid (ALA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: add-on placebo
Number of subjects: 20
Study: 34256810

Group type: EXPERIMENTAL
Intervention: Psycho-education intervention delivered by village health team (VHT) members, including information education and communication materials (IEC) aimed at improving MHL.
Number of subjects: 840

Group type: COMPARATOR
Intervention: Control group receiving ministry of health COVID-19 information leaflets distributed by VHTs.
Number of subjects: 840
Study: 35324910

Group type: EXPERIMENTAL
Intervention: Established community-based VAWG prevention intervention in Ghana
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Livelihoods intervention in South Africa
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combined small group and community-based programme
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: School-based interventions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Access to financial services in small groups
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Societal perspective interventions with positive economic impacts
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness acceptability curves (CEACs)
Number of subjects: 6
Study: 37084073

Group type: EXPERIMENTAL
Intervention: Combined physical activity training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Aerobic activity training
Number of subjects: 62
Study: 33058094

Group type: EXPERIMENTAL
Intervention: DSE technique
Number of subjects: 10

Group type: COMPARATOR
Intervention: Classic technique
Number of subjects: 10
Study: 32013568

Group type: EXPERIMENTAL
Intervention: Hypoxic Resistance Training (HRT; O2 = 14.4%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normoxic Resistance Training (NRT)
Number of subjects: 16
Study: 33001439

Group type: EXPERIMENTAL
Intervention: hemocoagulase (group A)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: gentamicin (group B)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: hemocoagulase plus gentamicin (group C)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: normal saline (group D)
Number of subjects: 910
Study: 32556827

Group type: EXPERIMENTAL
Intervention: Menopausal Hormone Therapy (MHT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal, newer low-dose oral therapies, and SERM therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36377410

Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (gPM+)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 410
Study: 32533702

Group type: EXPERIMENTAL
Intervention: Abnormal MRI findings
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal MRI findings
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal MRI group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Abnormal MRI group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Normal and abnormal MRI groups
Number of subjects: 35
Study: 35395866

Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor-1 (IGF-1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study: 34461024

Group type: EXPERIMENTAL
Intervention: Drinking according to thirst
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ad libitum drinking
Number of subjects: 10
Study: 32928119

Group type: EXPERIMENTAL
Intervention: Dynamic needle tip positioning (DNTP)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Angle-distance (AD)
Number of subjects: 131
Study: 33978967

Group type: EXPERIMENTAL
Intervention: Cued reflection
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Worked example
Number of subjects: 142

Group type: COMPARATOR
Intervention: Free reflection
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Cued reflection and worked example
Number of subjects: 142
Study: 32358375

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine cooperative therapy on the basis of conventional Western medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 0
Study: 36231486

Group type: EXPERIMENTAL
Intervention: Dyadic pain management program (eight-week group-based program with four weeks of center-based activities and four weeks of digital-based activities via WhatsApp)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care and a pain management pamphlet
Number of subjects: 0
Study: 35073968

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (25 mg/kg every 6 hours for up to 96 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (intravenous 5% dextrose)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34602419

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 75
Study: 36183143

Group type: EXPERIMENTAL
Intervention: Physiological-based cord clamping (PBCC)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Time-based delayed cord clamping (TBCC)
Number of subjects: 660
Study: 34082710

Group type: EXPERIMENTAL
Intervention: App-based sensorimotor home training
Number of subjects: 30

Group type: COMPARATOR
Intervention: App-based relaxation training (active control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study: 32188702

Group type: EXPERIMENTAL
Intervention: ?GalCer-pulsed APCs administered intravenously four times
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ?GalCer-pulsed APCs
Number of subjects: 35
Study: 35068364

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 74
Study: 34913980

Group type: EXPERIMENTAL
Intervention: Oral azithromycin, 10 mg/kg once daily for 3 days
Number of subjects: 8266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8266
Study: 32019551

Group type: EXPERIMENTAL
Intervention: School-based intervention targeting diet and physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study: 35697280

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 40
Study: 33983395

Group type: EXPERIMENTAL
Intervention: Level B (oxaliplatin 104 mg/m2, capecitabine 500 mg/m2)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Level C (oxaliplatin 78 mg/m2, capecitabine 375 mg/m2)
Number of subjects: 514

Group type: COMPARATOR
Intervention: CHEMO-BSC (Level C)
Number of subjects: 514
Study: 36297065

Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with L-arginine (ArgB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with branched-chain amino acids (BCAAsB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional wheat biscuit (CB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose solution (GS)
Number of subjects: 0
Study: 35225436

Group type: EXPERIMENTAL
Intervention: MyLupusGuideTM (immediate access)
Number of subjects: 541

Group type: COMPARATOR
Intervention: MyLupusGuideTM (delayed access)
Number of subjects: 541
Study: 34097705

Group type: EXPERIMENTAL
Intervention: Mathematical model of heparin clearance for protamine dosing
Number of subjects: 228

Group type: COMPARATOR
Intervention: Fixed ratio of 1 mg of protamine for every 100 IU of heparin
Number of subjects: 228
Study: 35907142

Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 54
Study: 34030591

Group type: EXPERIMENTAL
Intervention: US-guided percutaneous catheter placement and hydrostatic pressure irrigation combined with oral antibiotics
Number of subjects: 12
Study: 32475458

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 7.5 mg Cd/kg feed
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 15 mg Cd/kg feed
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 30 mg Cd/kg feed
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 60 mg Cd/kg feed
Number of subjects: 480
Study: 36251472

Group type: EXPERIMENTAL
Intervention: Nasal-tragus length + 1 cm (group N)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Weight + 6 cm (group W)
Number of subjects: 120
Study: 34474006

Group type: EXPERIMENTAL
Intervention: Participants who reported similar/less appetite than before pregnancy
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Participants who were sure they could control cravings
Number of subjects: 1005
Study: 32430334

Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1) monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 34881553

Group type: EXPERIMENTAL
Intervention: Caffeine (400mg dose of caffeine anhydrous)
Number of subjects: 12
Study: 32102535

Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services
Number of subjects: 0
Study: 36086792

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (GCBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (conventional treatment only)
Number of subjects: 128
Study: 33933058

Group type: EXPERIMENTAL
Intervention: Pigskin suturing model
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Sponge suturing model
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Commercial pad suturing model
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Orange suturing model
Number of subjects: 82

Group type: COMPARATOR
Intervention: All models
Number of subjects: 82
Study: 33358119

Group type: EXPERIMENTAL
Intervention: Inhaled aztreonam lysine plus IV colistimethate (AZLI+IV)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dual IV antibiotics (IV+IV)
Number of subjects: 16
Study: 34021668

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ultrasonic method
Number of subjects: 12
Study: 33436018

Group type: EXPERIMENTAL
Intervention: IBM score based on pre‐treatment contrast‐enhanced CT
Number of subjects: 154
Study: 32023545

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (HTCWI) at 14°C
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hot-water immersion (HTHWI) at 39°C
Number of subjects: 8

Group type: COMPARATOR
Intervention: Heat training (HT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (CON) at 24°C
Number of subjects: 8
Study: 35996967

Group type: EXPERIMENTAL
Intervention: Emblica officinalis extract (EOE) 2 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emblica officinalis extract (EOE) 1 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin 500 mg
Number of subjects: 0
Study: 34781358

Group type: EXPERIMENTAL
Intervention: Occupational Goal Intervention (OGI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Craft activities (control)
Number of subjects: 0
Study: 32996885

Group type: EXPERIMENTAL
Intervention: Blended periconception lifestyle intervention (combining outpatient lifestyle counseling and eHealth platform) for 24 weeks
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Blended periconception lifestyle intervention (for couples)
Number of subjects: 511
Study: 34216833

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking after meals (breakfast, lunch, dinner)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking on day 3
Number of subjects: 14
Study: 35100192

Group type: EXPERIMENTAL
Intervention: Titration of inspiratory support to obtain transdiaphragmatic pressure swings in the predefined 'diaphragm-protective' range (3-12 cm H2O)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 40
Study: 34021551

Group type: EXPERIMENTAL
Intervention: Internalizing problems (symptoms of depression measured by the shortened CES-D scale)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Externalizing problems (coexistence of behaviors such as substance abuse, violence, and delinquent behavior)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall mental health status
Number of subjects: 0
Study: 32611866

Group type: EXPERIMENTAL
Intervention: Benzocaine gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clove-papaya based anesthetic gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Precooling with ice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ice cone group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Benzocaine group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clove-papaya group
Number of subjects: 60
Study: 35151583

Group type: EXPERIMENTAL
Intervention: Pharmacist outreach intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 222
Study: 32102059

Group type: EXPERIMENTAL
Intervention: Mental fatigue induced by a 90 min incongruent Stroop color word test
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Reactive balance test (RBT) accuracy under mental fatigue
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Traditional functional performance tests (Y-balance test, single-leg hop, countermovement jump)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Visuomotor reaction time in the RBT
Number of subjects: 14
Study: 36263451

Group type: EXPERIMENTAL
Intervention: Daily emollient plus standard skin-care advice
Number of subjects: 1394

Group type: COMPARATOR
Intervention: Standard skin-care advice alone
Number of subjects: 1394
Study: 33931236

Group type: EXPERIMENTAL
Intervention: Emergency Severity Index (ESI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Japan Triage and Acuity Scale (JTAS)
Number of subjects: 23
Study: 34903129

Group type: EXPERIMENTAL
Intervention: Bright light exposure (approximately 10000 lux) for 3 hours before sleep
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control condition (< 50 lux) for 3 hours before sleep
Number of subjects: 10
Study: 32886456

Group type: EXPERIMENTAL
Intervention: Low time to surgery (TTS ≤ 5 weeks), n = 27
Number of subjects: 101

Group type: COMPARATOR
Intervention: High time to surgery (TTS > 5 weeks), n = 74
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low TTS after propensity matching
Number of subjects: 101
Study: 36364898

Group type: EXPERIMENTAL
Intervention: Vitamin C and E supplementation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 34015940

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily for 6 months (n=642)
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Placebo (n=638)
Number of subjects: 1280
Study: 32791362

Group type: EXPERIMENTAL
Intervention: Fractions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decimals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percentages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different notations (fractions, decimals, percentages)
Number of subjects: 0
Study: 33905304

Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study: 34473043

Group type: EXPERIMENTAL
Intervention: CABG + CD133+ implantation
Number of subjects: 26

Group type: COMPARATOR
Intervention: CABG only
Number of subjects: 26
Study: 35797505

Group type: EXPERIMENTAL
Intervention: Brief previsit counseling intervention
Number of subjects: 1270
Study: 33919631

Group type: EXPERIMENTAL
Intervention: Cepuna pear (Migo®)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Conference pear
Number of subjects: 15
Study: 32359142

Group type: COMPARATOR
Intervention: 0 g PRO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 15 g PRO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 30 g PRO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 45 g PRO
Number of subjects: 48
Study: 35303461

Group type: EXPERIMENTAL
Intervention: OptiMA strategy (a single programme for both severe acute malnutrition and moderate acute malnutrition using RUTF at a decreasing dose as MUAC and weight increased)
Number of subjects: 896

Group type: COMPARATOR
Intervention: Standard strategy (one programme for severe acute malnutrition using ready‐to‐use therapeutic food [RUTF] at an increasing dose as weight increased, another for moderate acute malnutrition using a fixed dose of ready‐to‐use supplementary food [RUSF])
Number of subjects: 896

Group type: EXPERIMENTAL
Intervention: OptiMA strategy
Number of subjects: 896

Group type: COMPARATOR
Intervention: Standard strategy
Number of subjects: 896
Study: 35996891

Group type: EXPERIMENTAL
Intervention: Pilates-based exercise classes (four-week, twice-weekly)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual exercise control
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Pilates-based exercise classes
Number of subjects: 46
Study: 33846987

Group type: EXPERIMENTAL
Intervention: Greater maximum LA volume (Vmax)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: LA emptying fraction in LA conduit phase
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Global and mean segmental peak LA radial strain (RS) and 3D strain (3DS)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Other strain parameters
Number of subjects: 217
Study: 32805081

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy (rituximab schedule)
Number of subjects: 318